John (Eddie) La Marca receives funding from Cancer Council Victoria. He is affiliated with the Olivia Newton-John Cancer Research Institute and the Walter and Eliza Hall Institute of Medical Research.

A new study conducted by Washington University School of Medicine in St. Louis researchers found that a single blood test could predict when someone is likely to develop Alzheimer’s disease. The study ...

New research shows a simple blood test can predict the onset of Alzheimer’s symptoms, leading to earlier therapeutic care Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously ...

A simple blood test could predict not only a person’s risk of developing Alzheimer’s disease, but also the year symptoms will begin. Researchers at the Washington University School of Medicine in St.

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to ...

Add Yahoo as a preferred source to see more of our stories on Google. A WashU study links a plasma tau marker to symptom timing, predicting Alzheimer’s onset within about three to four years. (CREDIT: ...

A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it. The test, called Galleri, failed to lower the number of people diagnosed ...

A man in a car looks down at his phone. “No cancer signal detected,” says a message on the screen. The man closes his eyes and smiles in relief. Why are so many young people getting cancer? What the ...

A large, three-year clinical trial designed to demonstrate how Grail’s blood test for early cancer detection could work in a broad population has preliminary results showing reduction in late-stage ...

A new plasma biomarker clock offers an early glimpse into Alzheimer’s timing, potentially reshaping prevention research and therapeutic trials. Alzheimer’s disease (AD) is a progressive neurocognitive ...